Table 2.
FAME 1 | PC3-EVs (n = 8) 2 | LNCaP-EVs (n = 8)2 |
---|---|---|
C14:0 | 4.38 ± 1.17 | 5.27 ± 0.25 |
C16:0 | 33.32 ± 0.74 | 35.62 ± 0.96 |
6trans-C16:1 | 0.10 ± 0.02 | 0.48 ± 0.03 *** |
6cis-C16:1 n-10 | 6.10 ± 1.59 | 8.13 ± 0.28 |
9cis-C16:1 n-7 | 1.10 ± 0.26 | 1.59 ± 0.08 |
C18:0 | 12.35 ± 0.52 | 15.34 ± 0.66 ** |
9trans-C18:1 | 0.18 ± 0.04 | 0.22 ± 0.04 |
8cis-C18:1 n-10 | 2.85 ± 0.67 | 4.32 ± 0.27 * |
9cis-C18:1 n-9 | 30.83 ± 4.41 | 15.43 ± 0.66 ** |
11cis-C18:1 n-7 | 1.21 ± 0.08 | 1.57 ± 0.24 |
5cis,8cis-C18:2 n-10 | 0.25 ± 0.03 | 0.62 ±0.07 *** |
mono-trans C18:2 n-6 | 0.15 ± 0.03 | 0.20 ± 0.06 |
C18:2 n-6 | 3.43 ± 0.50 | 2.91 ± 0.18 |
C20:3 n-6 | 0.49 ± 0.08 | 0.98 ± 0.16 * |
C20:4 n-6 | 0.70 ± 0.15 | 2.05 ± 0.13 *** |
mono-trans C20:4 | 0.05 ± 0.02 | 0.08 ± 0.02 |
C20:5 n-3 | 0.29 ± 0.05 | 0.55 ± 0.09 * |
C22:5 n-3 | 0.54 ± 0.14 | 1.41 ± 0.19 ** |
C22:6 n-3 | 1.68 ± 0.24 | 3.22 ± 0.23 *** |
SFA | 50.05 ± 1.50 | 56.23 ± 0.61 ** |
MUFA | 42.08 ± 2.25 | 31.05 ± 0.49 *** |
PUFA | 7.39 ± 0.94 | 11.74 ± 0.41 *** |
n-6 | 4.62 ± 0.57 | 5.94 ± 0.22 * |
n-3 | 2.51 ± 0.38 | 5.18 ± 0.32 *** |
n-6/n-3 | 1.97 ± 0.17 | 1.18 ± 0.08 *** |
n-10 | 9.20 ± 2.23 | 13.07 ± 0.50 |
Total trans | 0.48 ± 0.08 | 0.98 ± 0.09 |
1 Identified by standard references and quantified as described in the Materials and Methods Section. Values are obtained in µg/mL considering the GC peak areas recognized and calibrated with standard references (corresponding to >98% of the total peaks of the chromatogram). 2 EVs = extracellular vesicles. Values are expressed in percentages relative to the sum of all the quantities of the recognized peaks ± standard error of the mean (S.E.M) from the analyses of n = 8 cell samples of each type; statistical significance is estimated: * p-value ≤ 0.05; ** p-value ≤ 0.003; *** p-value ≤ 0.0006. Details of the statistical analysis are reported in the Materials and Methods Section.